NOVACYT EO-0667
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive h… Read more
Market Cap & Net Worth: NOVACYT EO-0667 (NYZ)
NOVACYT EO-0667 (F:NYZ) has a market capitalization of $26.32 Million (€25.64 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #24235 globally and #2644 in its home market, demonstrating a -1.36% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NOVACYT EO-0667's stock price €0.36 by its total outstanding shares 70626248 (70.63 Million).
NOVACYT EO-0667 Market Cap History: 2018 to 2026
NOVACYT EO-0667's market capitalization history from 2018 to 2026. Data shows change from $25.84 Million to $26.32 Million (-4.76% CAGR).
NOVACYT EO-0667 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NOVACYT EO-0667's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NYZ by Market Capitalization
Companies near NOVACYT EO-0667 in the global market cap rankings as of March 19, 2026.
Key companies related to NOVACYT EO-0667 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
NOVACYT EO-0667 Historical Marketcap From 2018 to 2026
Between 2018 and today, NOVACYT EO-0667's market cap moved from $25.84 Million to $ 26.32 Million, with a yearly change of -4.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €26.32 Million | -0.55% |
| 2025 | €26.46 Million | -36.19% |
| 2024 | €41.47 Million | -15.94% |
| 2023 | €49.33 Million | -43.29% |
| 2022 | €87.00 Million | -72.66% |
| 2021 | €318.18 Million | -50.74% |
| 2020 | €645.94 Million | +6743.32% |
| 2019 | €9.44 Million | -63.48% |
| 2018 | €25.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NOVACYT EO-0667 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.32 Million USD |
| MoneyControl | $26.32 Million USD |
| MarketWatch | $26.32 Million USD |
| marketcap.company | $26.32 Million USD |
| Reuters | $26.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.